These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 17588620)
1. Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides. Sheng Z; Dai Q; Prorok M; Castellino FJ Neuropharmacology; 2007 Jul; 53(1):145-56. PubMed ID: 17588620 [TBL] [Abstract][Full Text] [Related]
2. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. Klein RC; Prorok M; Galdzicki Z; Castellino FJ J Biol Chem; 2001 Jul; 276(29):26860-7. PubMed ID: 11335724 [TBL] [Abstract][Full Text] [Related]
3. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors. Sheng Z; Prorok M; Castellino FJ Neuroscience; 2010 Oct; 170(3):703-10. PubMed ID: 20688135 [TBL] [Abstract][Full Text] [Related]
4. The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B. Sheng Z; Liang Z; Geiger JH; Prorok M; Castellino FJ Neuropharmacology; 2009 Aug; 57(2):127-36. PubMed ID: 19427876 [TBL] [Abstract][Full Text] [Related]
5. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors. Kurkó D; Dezso P; Boros A; Kolok S; Fodor L; Nagy J; Szombathelyi Z Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435 [TBL] [Abstract][Full Text] [Related]
6. Helix-helix interactions between homo- and heterodimeric gamma-carboxyglutamate-containing conantokin peptides and their derivatives. Dai Q; Sheng Z; Geiger JH; Castellino FJ; Prorok M J Biol Chem; 2007 Apr; 282(17):12641-9. PubMed ID: 17347154 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators. Nielsen KJ; Skjaerbaek N; Dooley M; Adams DA; Mortensen M; Dodd PR; Craik DJ; Alewood PF; Lewis RJ J Med Chem; 1999 Feb; 42(3):415-26. PubMed ID: 9986713 [TBL] [Abstract][Full Text] [Related]
8. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology. Monaghan DT; Larsen H J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological analysis of recombinant NR1a/2A and NR1a/2B NMDA receptors using the whole-cell patch-clamp method. Fodor L; Nagy J Methods Mol Biol; 2007; 403():3-13. PubMed ID: 18827984 [TBL] [Abstract][Full Text] [Related]
11. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398 [TBL] [Abstract][Full Text] [Related]
12. The molecular basis of conantokin antagonism of NMDA receptor function. Prorok M; Castellino FJ Curr Drug Targets; 2007 May; 8(5):633-42. PubMed ID: 17504106 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons. Klein RC; Galdzicki Z; Castellino FJ Neuropharmacology; 1999 Dec; 38(12):1819-29. PubMed ID: 10608277 [TBL] [Abstract][Full Text] [Related]
15. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Williams K Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753 [TBL] [Abstract][Full Text] [Related]
16. NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins. Xiao C; Huang Y; Dong M; Hu J; Hou S; Castellino FJ; Prorok M; Dai Q Neuropeptides; 2008; 42(5-6):601-9. PubMed ID: 18992939 [TBL] [Abstract][Full Text] [Related]
17. Sequence requirements for the N-methyl-D-aspartate receptor antagonist activity of conantokin-R. Blandl T; Zajicek J; Prorok M; Castellino FJ J Biol Chem; 2001 Mar; 276(10):7391-6. PubMed ID: 11096077 [TBL] [Abstract][Full Text] [Related]
18. Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities toward Ion Channels of N-Methyl-d-aspartate Receptors. Kunda S; Yuan Y; Balsara RD; Zajicek J; Castellino FJ J Biol Chem; 2015 Jul; 290(29):18156-18172. PubMed ID: 26048991 [TBL] [Abstract][Full Text] [Related]